Medline shareholders launch $35.50 per share 60‑million share offering with $200 million buyback
Selling shareholders of Medline Inc., including Blackstone, Carlyle, Hellman & Friedman, GIC and an ADIA subsidiary, began an underwritten public offering of 60 million Class A shares at $35.50 each, with a 30‑day option for underwriters to purchase up to an additional 9 million shares. Medline itself will not sell any stock or receive proceeds, but has agreed to buy back $200 million of shares and partnership interests from the sellers at the same price paid by the underwriters. Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan are acting as global coordinators and joint book‑running managers.
Why it matters
The offering creates new shares that could dilute existing holders, while the simultaneous $200 million repurchase offsets that dilution and returns cash to the selling shareholders. Investors should watch the closing of both the offering and the buyback, as the transaction will affect Medline’s share count and liquidity.
Key facts
- 1Selling shareholders affiliated with Blackstone, Carlyle, Hellman & Friedman, GIC and an ADIA subsidiary launched the offering. investing.com
- 2The offering comprises 60 million Class A common shares with a 30‑day option for underwriters to buy up to 9 million additional shares. investing.com
- 3The shares were priced at $35.50 per share. tradingview.com
- 4Medline will repurchase $200 million of its Class A shares and limited partnership interests directly from the selling shareholders. investing.com
- 5The repurchase price will match the price paid by underwriters in the offering. investing.com
- 6Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan serve as global coordinators and joint book‑running managers. investing.com
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.